Home/Velvio/Dr. Torsten Mummenbrauer
DT

Dr. Torsten Mummenbrauer

Chief Executive Officer

Velvio

Velvio Pipeline

DrugIndicationPhase
NVP-13Amyotrophic Lateral Sclerosis (ALS)Pre-clinical
Immune-Oncology ProgramsSolid TumorsResearch
Liver Disease ProgramsLiver Disease (e.g., fibrosis)Research